Recently, the 3rd ZAODX World Cancer Early Screening Conference was held at the Xiong'an Convention and Exhibition Center in Xiong'an New Area, Hebei Province. This conference is a high-end event in the field of cancer early screening, bringing together experts, scholars, and entrepreneurs in the fields of industry, academia, research, and medicine from multiple countries and regions around the world. It further promotes the innovation and application of cancer early screening technology, attracting nearly 4000 offline visitors and millions of online visitors. At the same time, the list of the third "Golden Screen Award" selection activity initiated by the Early Screening Website was also unveiled at the meeting.

Dunwill Medical has won the Golden Screen Award "Future Unicorn Enterprise Award" for its unremitting technological innovation, origina clinical IVD product R&D ability, and influence in the field of tumor early screening, demonstrating Dunwill Medical's outstanding strength and huge potential in the field of cancer early screening!

This honor is not only a recognition of Dunwill's unremitting efforts over the years in the industry, but also foreshadows the broad prospects for the company's future development. Looking to the future, Dunwill Medical will continue to take it as its responsibility to create more possibilities for modern medicine, continuously pursue innovation and breakthroughs, and further promote the formation of original clinical IVD products with independent intellectual property rights. At the same time, we also look forward to cooperating with more medical institutions and research teams to provide more accurate and efficient solutions for clinical diagnosis and research services, assist in the development of early screening and diagnosis technology, and make greater contributions to the global cancer prevention and treatment industry.